Ipca Laboratories Ltd share price logo

Ipca Laboratories Ltd

NSE: IPCALAB

BSE: 524494

Mid Cap

Pharma Sector

₹1701.00

+53.80

(+3.27%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Block Trade Alert

IPCA Laboratories witnessed an NSE block trade of approximately 100,641 shares valued at Rs. 16.94 crore at Rs. 1683.40 per share.

Ipca Laboratories Stock Performance

as on June 30, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,635.80
    ₹1,736.00
    downward going graph

    3.83%

    Downside

    2.06%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,251.60
    ₹1,736.00
    downward going graph

    26.42%

    Downside

    2.06%

    Upside

    downward going graph

Ipca Laboratories share price movements today

Previous Close
₹1,647.20
Open
₹1,649.00
Volume
9.19L
Upper Circuit
₹1,976.60
Lower Circuit
₹1,317.80
Day's Low - High
₹1,635.80 - ₹1,736.00
52 Week Low - High
₹1,251.60 - ₹1,736.00

Ipca Laboratories Historical Returns

1 Month Return
+ 10.52 %
3 Month Return
+ 2.87 %
1 Year Return
+ 18.52 %
3 Year Return
+ 121.74 %
5 Year Return
+ 62.57 %

Ipca Laboratories Fundamentals

as on June 30, 2026 at 4:01 pm IST

Market Cap

₹41,790.16 Cr

Return on Equity (ROE)

12.39

PE Ratio (TTM)

35.42

Return on capital employed (ROCE)

17.21

Industry PE ratio

47.33

Beta (LTM)

-0.02

P/B Ratio

5.53

Dividend Yield

0.27

PEG Ratio

2.03

Quarterly Earnings Growth YOY

370.36

EPS (TTM)

31.04

Book Value

273.88

Ipca Laboratories Stock Valuation

as on June 30, 2026 at 4:01 pm IST

Ipca Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (18.72x)

October 10, 2019

Today (35.42x)

June 29, 2026

Industry (47.33x)

June 29, 2026

Highest (65.89x)

September 25, 2024

LowHigh

Today’s Price to Earnings Ratio: 35.42x

Ipca Laboratories Technical Analysis

Track how Ipca Laboratories technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish4
Bullish9
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
-1.27
Bullish
CCI (20)
-219.02
Bullish
RSI (14)
58.25
Neutral
Momentum (10)
6.5
Bullish
ADI (14)
54.45
Bullish
Ultimate Oscillator (7,14,28)
67.6
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1699.97
Bullish
EMA (20)
1700.95
Bullish
VWMA (20)
1699.6
Bullish
SMA (50)
1705.17
Bearish
EMA (50)
1705
Bullish
SMA (200)
1709.77
Bearish
EMA (200)
1703.58
Bullish
KAMA (200)
1705.39
Bearish
DEMA (200)
1718.46
Bearish

Ipca Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ipca Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Ipca Laboratories Ltd image
Ipca Laboratories Ltd
BUY41,790.1612.51%0.657878,939
Sanofi India Ltd image
Sanofi India Ltd
BUY7,753.51-11.22%0.004132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY89,879.0512.07%0.603,48331,723
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
BUY1,12,829.0214.76%0.614,61423,241
Abbott India Ltd image
Abbott India Ltd
BUY53,751.8810.1%0.001,4146,445
See all

Market expectation of Ipca Laboratories Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Ipca Laboratories Stock’s Investor Sentiment and Interest

Investment in Ipca Laboratories Ltd Shares on INDmoney has dropped by -15.97% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-15.97% versus previous 30 day period

Search interest for Ipca Laboratories Ltd Stock has decreased by -2% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-2% versus previous 30 day period

Ipca Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
2,033.96
2,052.85
2,033.03
2,092.63
2,354.9
2,245.37
2,246.69
2,308.85
2,556.5
2,392.5
2,388.48
Other Income
38.55
90.91
18.92
20.61
26.26
20.11
25.82
32.66
27.86
37.84
93.74
Total Income
2,072.51
2,143.76
2,051.95
2,113.24
2,381.16
2,265.48
2,272.51
2,341.51
2,584.36
2,430.34
2,482.22
Expenses
1,712.69
1,721.97
1,847.85
1,699.91
1,913.42
1,782.29
2,022.88
1,892.43
2,069.84
1,859.15
1,950.43
Operating Profit
321.27
330.88
185.18
392.72
441.48
463.08
223.81
416.42
486.66
533.35
438.05
Operating Profit Margin %
15.8%
16.12%
9.11%
18.77%
18.75%
20.62%
9.96%
18.04%
19.04%
22.29%
18.34%
Profit Before Interest, Tax and Depreciation
359.82
421.79
204.1
413.33
467.74
483.19
249.63
449.08
514.52
571.19
531.79
Interest
44.12
33.4
29.37
24.05
22.56
16.81
21.51
18.51
19.61
17.62
20.2
Depreciation
90.34
99.5
98.13
98.89
100.35
98.46
100.12
100.06
103.33
107.59
107.14
Profit Before Tax
225.36
288.89
76.6
290.39
344.83
367.92
128
330.51
391.58
445.98
404.45
Tax Paid
87.92
66.24
73.69
91.41
99.39
90.59
62.22
96.09
108.08
81.93
95.05
Profit After Tax
137.44
222.65
2.91
198.98
245.44
277.33
65.78
234.42
283.5
364.05
309.4
Total Net profit including share of profit / Loss from associate company
136.49
221
1.33
199.14
245.75
276.36
63.99
232.89
280.53
363.67
306.69
EPS
5.72
7.09
2.35
7.58
9.05
9.78
2.67
9.19
11.14
12.86
13.31
Actual EPS
5.72
7.09
2.35
7.58
9.05
9.78
2.67
9.19
11.14
12.86
13.31
Adjusted EPS
5.72
7.09
2.35
7.58
9.05
9.78
2.67
9.19
11.14
12.86
13.31
Diluted EPS
5.72
7.09
2.35
7.58
9.05
9.78
2.67
9.19
11.14
12.86
11.79

Ipca Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
3,283.57
3,773.18
4,648.71
5,419.99
5,829.79
6,244.32
7,705.04
8,939.59
9,646.33
Other Income
41.8
57.68
67
62.84
66.57
125.62
124.77
92.8
174.45
Total Income
3,325.37
3,830.86
4,715.71
5,482.83
5,896.36
6,369.94
7,829.81
9,032.39
9,820.78
Expenses
2,833.09
3,083.11
3,749.82
3,875.64
4,520.53
5,317.55
6,491.63
7,418.5
7,754.2
Operating Profit
450.48
690.07
898.89
1,544.35
1,309.26
926.77
1,213.41
1,521.09
1,892.13
Operating Profit Margin %
13.72%
18.29%
19.34%
28.49%
22.46%
14.84%
15.75%
17.02%
19.62%
Profit Before Interest, Tax and Depreciation
492.28
747.75
965.89
1,607.19
1,375.83
1,052.39
1,338.18
1,613.89
2,066.58
Interest
24.02
18.87
16.5
9.04
7.69
45.54
138.27
84.93
75.94
Depreciation
177.73
182.42
210.5
209.17
232.42
261.56
357.24
397.82
418.12
Profit Before Tax
290.53
546.46
738.89
1,388.98
1,135.72
745.29
842.67
1,131.14
1,572.52
Tax Paid
51.11
104.24
135.33
240.14
224.77
253.36
313.46
343.61
381.15
Profit After Tax
239.42
442.22
603.56
1,148.84
910.95
491.93
529.21
787.53
1,191.37
Total Net profit including share of profit / Loss from associate company
239.42
442.22
603.56
1,141.14
889.79
478.99
522.92
785.24
1,183.78
EPS
18.97
35.01
47.77
90.02
34.85
18.58
21.57
29.08
46.94
Actual EPS
18.97
35.01
47.77
90.02
34.85
18.58
21.57
29.08
46.94
Adjusted EPS
9.49
17.51
23.89
45.01
34.85
18.58
21.57
29.08
46.94
Diluted EPS
18.97
35.01
47.73
90.02
34.85
18.58
21.57
29.08
44.98

Ipca Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
708.65
281.91
341.13
501.03
570.35
1,090.13
856.04
805.81
944.65
1,321.32
Cash Flow from Investing Activities
-223.69
-145.42
-135.4
-179.92
-509.34
-520.69
-850.93
-725
-1,215.29
-869.5
Cash Flow from Financing Activities
-456.51
-154.13
-125.41
-183.2
-136.54
-305.82
426.81
507.24
-552.55
-282.98
Net Cash Flow
28.81
-26.04
75.32
152.77
-75.53
263.62
431.92
588.05
-823.19
168.84

Ipca Laboratories Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
46.29%
46.29%
46.3%
46.3%
46.3%
44.72%
44.72%
44.72%
44.72%
44.72%
44.72%
DII
35.05%
33.79%
34.37%
33.78%
34.23%
35.68%
36.06%
36.2%
36.77%
37.32%
37.45%
FII
9.86%
0%
10.51%
10.85%
10.83%
11.07%
10.76%
10.67%
10.43%
10.63%
10.63%
Public
8.81%
8.92%
8.82%
9.06%
8.64%
8.53%
8.46%
8.41%
8.07%
7.33%
7.2%
Total Outstanding Shares
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
Total Shareholders
95,930
82,809
81,165
84,753
82,975
90,189
88,306
85,582
82,870
77,673
82,184

Mutual Funds that own Ipca Laboratories Stock

Check out the Mutual Funds with significant holdings in Ipca Laboratories.

Ipca Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Ipca Laboratories.

  • Ipca Laboratories Ltd Earnings Results

    Ipca Laboratories Ltd’s net profit jumped 340.98% since last year same period to ₹299.07Cr in the Q4 2025-2026. On a quarterly growth basis, Ipca Laboratories Ltd has generated -8.34% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Ipca Laboratories Ltd Dividends May,2025

    In the quarter ending March 2025, Ipca Laboratories Ltd has declared dividend of ₹2.00 per share on 29 May 2025 - translating a dividend yield of 0.36%.

    Read More about Dividends

Indices Featuring Ipca Laboratories Stock

Check stock indices that include Ipca Laboratories.

NIFTY PHARMA

₹25,326.40

98.50 (▲0.39%)

BSE 500

₹35,958.71

-2.27 (▲0.01%)

Nifty 500

₹22,995.65

-4.35 (▲0.02%)

S&P BSE 400 MidSmallCap

₹12,477.49

58.85 (▲0.47%)

BSE Healthcare

₹49,305.54

282.49 (▲0.58%)

Nifty Healthcare

₹16,139.75

26.35 (▲0.16%)

S&P BSE 150 MidCap

₹16,663.41

75.36 (▲0.45%)

S&P BSE 250 LargeMidCap

₹10,635.78

-7.26 (▲0.07%)

Nifty LargeMidcap 250

₹16,476.35

14.05 (▲0.09%)

Nifty Midcap 150

₹22,774.25

94.60 (▲0.42%)

Nifty MidSmallcap 400

₹20,932.80

97.90 (▲0.47%)

Insights on Ipca Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.43K Cr → 2.48K Cr (in ₹), with an average increase of 2.1% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 30.52% to 31.24% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, IPCALAB stock has moved up by 10.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.72% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 36.7% return, outperforming this stock by 18.1%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 10.63% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 144.5% return, outperforming this stock by 22.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 326.27 Cr → 299.07 Cr (in ₹), with an average decrease of 8.3% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.33% to 7.20% in Mar 2026 quarter

About Ipca Laboratories Ltd

Ipca Laboratories is a fully integrated global pharmaceutical company, manufacturing and marketing over 350 formulations and 80 APIs in over 100 countries around the world. Established in 1949, with its original name as Indian Pharmaceutical Combine Association Limited, Ipca has 17 manufacturing units in India, producing APIs and Formulations that are approved by major drug regulatory authorities, including the US FDA, UK MHRA, South African MCC, Brazilian ANVISA and Australian TGA. Apart from native India, Ipca is also a recognized supplier of intermediates and APIs⁠—Atenolol, Chloroquine Phosphate, Furosemide, and Pyrantel Salts⁠—globally. Ipca has received accreditation from ISO 9001, Forbes Global 200 best small companies, WHOGMP, INVIMA Colombian, and German standards, making it a respected name in the pharmaceutical industry. Recently, Ipca has acquired a number of companies, namely Krebs Biochemicals and Industries Ltd., Pisgah Labs Inc., Trophic Wellness Private Ltd, Lyka Labs Limited, and M/s. Ramdev Chemical Private Limited, to further extend its presence in the global market.

Revenue: ₹2,388.48Cr as on March 2026 (Q4 FY26)
Net Profit: ₹309.40Cr as on March 2026 (Q4 FY26)
Listing date: 03 Nov, 1994
Chairperson Name: Premchand Godha
OrganisationIpca Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOPremchand Godha
E-voting on sharesClick here to vote

FAQs

What is Ipca Laboratories share price today?

Ipca Laboratories share price today stands at ₹1701 as on at the close of the market. Ipca Laboratories share today touched a day high of ₹1736 and a low of ₹1635.8.

What is the 52 week high and 52 week low range for Ipca Laboratories share?

Ipca Laboratories touched a 52 week high of ₹1736 and a 52 week low of ₹1251.6. Ipca Laboratories share price today i.e. is closed at ₹1701, which is -2.02% down from its 52 week high and 35.91% up from its 52 week low.

What is Ipca Laboratories's market capitalisation today?

Ipca Laboratories market capitalisation is ₹41,790.16 Cr as on .

How to buy Ipca Laboratories shares?

To buy Ipca Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for IPCALAB or Ipca Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Ipca Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Ipca Laboratories trading volume today?

Ipca Laboratories trading volume is 9.19L as on . This means that 9.19L shares of Ipca Laboratories were bought and sold on the stock market during today's trading session.